Admission Date:  [**2183-11-4**]              Discharge Date:   [**2183-11-5**]  Date of Birth:  [**2119-11-18**]             Sex:   F  Service: MEDICINE  Allergies: Penicillins / Tetracycline / IV Dye, Iodine Containing Contrast Media  Attending:[**First Name3 (LF) 338**] Chief Complaint: carboplatin desensitization   Major Surgical or Invasive Procedure: None  History of Present Illness: 63F with stage IIIC poorly differentiated primary peritoneal serous carcinoma, now with disease recurrence and participating in a [**Company 2860**] clinical trial, admitted to the ICU for cycle 5 of [**Doctor Last Name **]/taxol therapy with carboplatin desensitization.
One third of the way through infusion of carboplatin during cycle 2 of chemotherapy on [**2183-9-2**], she developed an intense feeling of heat and generalized body tingling, numbness and tingling of the lips, and chest tightness.
Carboplatin was discontinued and she received 100 mg hydrocortisone and 50 mg of Benadryl IV.
Given her allergic reaction, she was admitted to the ICU to receive cycles 3 and 4 of carboplatin per the desensitization protocol.
She has tolerated the treatments without incident.
Today, she is directly admitted to the ICU again for carboplatin desensitization for cycle 5 of chemotherapy.
Past Medical History: - Stage IIIC poorly differentiated primary peritoneal serous carcinoma - Thalassemia - Hypertension (per patient never treated with home medication, only when in hospital or seeing doctors) - Gastritis/Reflux  Oncologic history - CT abd/pelvis on [**2182-2-28**] revealed a large mass centered in the sigmoid colon with pelvic lymphadenopathy, retroperitoneal lymphadenopathy, and peritoneal carcinomatosis.
- [**2182-3-14**] underwent exploratory laparotomy, hysterectomy, bilateral salpingo-oophorectomy, rectosigmoid resection with colorectal re anastomosis and diverting loop ileostomy.
- [**Date range (3) 88205**]: 5 cycles of chemotherapy with Carboplatin q21 days and weekly Taxol, [**2182-8-15**] 6th cycle of chemotherapy with Carboplatin and Taxotere in place of Taxol due to neurotoxicity - [**2183-7-12**]: MRI of the L-spine shows new retroperitoneal lymphadenopathy consistent with disease recurrence.
- [**2183-8-11**] started chemotherapy according to the clinical trial [**Company 2860**] #11-228 (Phase II, multi-center, double-blind, placebo controlled, randomized study of ombrabulin in patients with platinum-sensitive recurrent ovarian cancer treated with Carboplatin/Paclitaxel)   Social History: Immigrated from [**Country 3587**] in youth.
Physical Exam: Admission physical exam: Vitals:  T 91, BP 122/71, HR 82, RR 19, SpO2 93% RA General: NAD, comfortable HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: supple, no JVD appreciated, no LD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound or guarding, epigastric hernia that is reducible, two large healed surgical scar from resection of cancer and cholecystectomy Ext: Warm, well perfused, 2+ pulses, 1+ edema up to knees Neuro: CNII-XII intact, downgoing babinski  Discharge physical exam: Vitals:  T 98.4, BP 119/68, HR 80, RR 23, SpO2 94% RA General: NAD, comfortable HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: supple, no JVD appreciated, no LD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound or guarding, epigastric hernia that is reducible, two large healed surgical scar from resection of cancer and cholecystectomy Ext: Warm, well perfused, 2+ pulses, 1+ edema up to knees Neuro: CNII-XII intact   Pertinent Results: Admission labs: [**2183-11-3**] 10:05AM BLOOD WBC-3.7*# RBC-3.84* Hgb-8.9* Hct-27.8* MCV-72* MCH-23.1* MCHC-32.0 RDW-20.1* Plt Ct-211 [**2183-11-3**] 10:05AM BLOOD Neuts-48.9* Lymphs-42.6* Monos-7.1 Eos-1.3 Baso-0.2 [**2183-11-3**] 10:05AM BLOOD PT-11.2 INR(PT)-1.0 [**2183-11-3**] 10:05AM BLOOD UreaN-21* Creat-0.8 Na-143 K-3.6 Cl-105 [**2183-11-3**] 10:05AM BLOOD Glucose-182* [**2183-11-3**] 10:05AM BLOOD TotProt-6.9 Albumin-4.3 Globuln-2.6 Calcium-8.9 Phos-3.8 Mg-1.6 [**2183-11-3**] 10:05AM BLOOD ALT-36 AST-32 AlkPhos-103 TotBili-0.3 DirBili-0.1 IndBili-0.2 [**2183-11-4**] 01:48PM BLOOD ALT-35 AST-29 LD(LDH)-267* AlkPhos-112* TotBili-0.3 [**2183-11-3**] 10:05AM BLOOD CA125-40*  Discharge labs: [**2183-11-5**] 04:18AM BLOOD WBC-7.1# RBC-3.68* Hgb-8.2* Hct-26.1* MCV-71* MCH-22.4* MCHC-31.5 RDW-21.0* Plt Ct-202 [**2183-11-5**] 04:18AM BLOOD Glucose-156* UreaN-23* Creat-0.9 Na-141 K-4.3 Cl-105 HCO3-24 AnGap-16 [**2183-11-5**] 04:18AM BLOOD ALT-33 AST-29 AlkPhos-93 TotBili-0.4 [**2183-11-5**] 04:18AM BLOOD Calcium-9.2 Phos-4.1 Mg-1.7  Studies: None  Micro: None    Brief Hospital Course: 63F with stage IIIC poorly differentiated primary peritoneal serous carcinoma, now with disease recurrence and participating in a [**Company 2860**] clinical trial, admitted to the ICU for cycle 5 of [**Doctor Last Name **]/taxol therapy with carboplatin desensitization.
# Carboplatin desensitization: Cycle 2 was complicated by an allergic reaction after infusion of carboplatin which included a feeling of heat, generalized body tingling, numbness of the lips, chest tightness, nausea, and headache.
Patient was admitted to the ICU for cycles 3 and 4 with carboplatin desensitization per protocol, and tolerated both cycles well.
She underwent carboplatin desensitization per protocol for cycle 5 of [**Doctor Last Name **]/taxol and tolerated well.
# Stage IIIc poorly differentiated primary peritoneal serous carcinoma: Status post sub-optimal debulking surgery ([**2182-3-14**]) and 6 cycles of chemotherapy ([**4-/2182**]/[**2182**]); five cycles with Carboplatin and weekly Taxol and 1 cycle with Carboplatin and Taxotere.
On [**8-11**], she started chemotherapy according to the clinical trial [**Company 2860**] #11-228 (Phase II, multi-center, double-blind, placebo controlled, randomized study of ombrabulin in patients with platinum-sensitive recurrent ovarian cancer treated with Carboplatin/Paclitaxel).
The second cycle was complicated by an allergic reaction to carboplatin (see above), but cycles 3 and 4 were administered per the carboplatin desensitization protocol without complication.
She completed cycle 5 of chemotherapy during this admission per [**Company 2860**] clinical trial #11-228 and tolerated desensitization well (above).
QTc was monitored while receiving high doses of ondansetron and remained within normal limits.
# Prophylaxis: heparin sq # Communication: Patient # Code: Full code # Transitional Issue: -patient has follow up with heme/onc on [**2183-11-11**]  Medications on Admission: Preadmission medications listed are correct and complete.
Ondansetron 8 mg PO BID:PRN nausea 2.
Lorazepam 0.5 mg PO Q8H:PRN anxiety 3.
Docusate Sodium 100 mg PO BID 4.
Senna 1 TAB PO BID:PRN constipation   Discharge Disposition: Home  Discharge Diagnosis: Carboplatin desensitization  Discharge Condition: Mental Status: Clear and coherent.
Discharge Instructions: Dear Ms. [**Known lastname 47639**],  It was a pleasure taking care of you during your hospitalization at [**Hospital1 18**].
You were hospitalized to make sure that you did not have an adverse reaction while receiving your chemotherapy medications.
You received your medications without any problems.
Followup Instructions: Department: HEMATOLOGY/ONCOLOGY When: TUESDAY [**2183-11-11**] at 8:45 AM With: CHECKIN HEM ONC CC9 [**Telephone/Fax (1) 22**] Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) 24**] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage  Department: HEMATOLOGY/ONCOLOGY When: TUESDAY [**2183-11-11**] at 9:30 AM With: [**First Name8 (NamePattern2) 4617**] [**Last Name (NamePattern1) 26978**], RN [**Telephone/Fax (1) 9644**] Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) 24**] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage  Department: HEMATOLOGY/ONCOLOGY When: MONDAY [**2183-11-24**] at 7:45 AM With: CHECKIN HEM ONC CC9 [**Telephone/Fax (1) 22**] Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) 24**] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage   Completed by:[**2183-11-5**
